Merck sought to reformulate Vioxx in 2000 - report

NEW YORK (Reuters) - Merck & Co. Inc. researchers sought to reformulate the arthritis drug Vioxx five years ago to reduce its cardiovascular side effects, even as the company publicly played down data showing potential heart attack risk, according to a report by the Associated Press.

Continue to Merck sought to reformulate Vioxx in 2000 - report on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz